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ABSTRACT
OBJECTIVE: To assess risk factors for retreatment of leprosy patients.
METHODS: A case-control study with patients from two reference care units in 
Recife, northeastern Brazil, in 2003. The case group included retreated patients 
(N=155) and the control group comprised those patients who were not retreated 
(N=155) matched by year of diagnosis and health care unit. Univariate and 
multivariate analyses were conducted to test the associations and odds ratios 
and related 95% confi dence intervals were estimated.
RESULTS: The following factors were found to be signifi cantly associated 
(p<0.05) with retreatment: occurrence of adverse immunological reactions 
after treatment completion (OR=2.3; 95% CI=1.18;4.83), fi nal bacterial index 
> 1 (OR=6.43; 95% CI=1.67;24.74), therapeutic regimen consisting of sulfone 
monotherapy (OR=10; 95% CI=0.01;0.78) and reports of household contacts 
(OR=2.2; 95% CI=0.24;0.85).
CONCLUSIONS: The study fi ndings reinforce that the use of dapsone 
monotherapy should be discontinued, and highlight the need for epidemiological 
monitoring of specifi c groups of leprosy patients after treatment completion 
through periodical clinical and laboratory evaluation. Further studies to explore 
the association between fi nal bacterial index and retreatment are strongly 
recommended.
KEY WORDS: Leprosy, epidemiology. Leprosy, therapy. Leprostatic 
agents, administration & dosage. Treatment outcome. Recurrence, pre-
vention & control. Case-control studies.
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RESUMO
OBJETIVO: Analisar os fatores de risco para retratamento da hanseníase.
MÉTODOS: Estudo de caso-controle com pacientes de duas unidades de 
referência para tratamento da hanseníase, em Recife, Pernambuco, no de 
2003. O grupo de casos incluiu pacientes retratados (N=155) e foi comparado 
com o grupo controle (N=155), pacientes não retratados pareados por ano-
diagnóstico e unidade de saúde. Para testar as associações foram realizadas 
análises uni e multivariadas, e calculados odds ratios com respectivos 
intervalos de confi ança de 95%.
RESULTADOS: Os seguintes fatores apresentaram associação estatisti-
camente signifi cante (p<0,05) com retratamento: reação hansênica após 
tratamento (OR=2,3; IC 95%:1,18;4,83); índice baciloscópico fi nal > 1 
(OR=6,43; IC 95%:1,67;24,74); tratamento com a monoterapia sulfônica 
(OR=10; IC 95%: 0,01;0,78); relato de contato intradomiciliar com porta-
dores de hanseníase (OR=2,2; IC 95%:0,24;0,85).
CONCLUSÕES: Os resultados reforçam o desuso da monoterapia sulfônica 
e apontam a necessidade de se monitorizar grupos específi cos de pacientes 
após alta terapêutica, através do acompanhamento clínico e laboratorial 
periódico. Recomenda-se a realização de novos estudos para explorar a 
associação entre o índice baciloscópico fi nal e retratamento.
DESCRITORES: Hanseníase, epidemiologia. Hanseníase, terapia. 
Hansenostáticos, administração e dosagem. Resultado de tratamento. 
Recidiva, prevenção e controle. Estudos de casos e controles.
The major indicator of treatment effectiveness in 
leprosy cases is low relapse rate after its completion. 
Offi cial Brazilian data from Sistema Nacional de Agra-
vos de Notifi cação (Disease Reporting National System 
– SINAN, 2002)* show that from 1994 to 2000 nearly 
4,500 patients were reintroduced into the multidrug 
therapy (MTD)/World Health Organization (WHO) 
regimens, thus once again becoming part of the active 
record and showing increasing prevalence. Of these, 
2,221 cases were diagnosed as relapses. In 2002 only, 
1,394 cases of relapse were reported.
Relapse rates may be overestimated. Several authors 
have pointed out the occurrence of adverse immu-
nological reactions after completion of therapeutic 
treatment.1,5,9,10 These events are quite frequent in the 
fi rst years after treatment, but they need to be differen-
tiated from relapses, requiring clinical and laboratory 
resources.
It is diffi cult to apply the criteria proposed for diag-
nosing relapse or differentiating it from a leprosy 
reaction, especially in primary care settings. This is 
due to the lack of information and standardization in 
medical records of patients treated in different health 
units and Brazilian regions, as well as non-performance 
or lack of reliability of slit-skin smear and histological 
examinations.
The objective of the present study was to investigate 
risk factors for leprosy retreatment since there is little 
reference to these factors in the literature.
METHODS
The study was carried out at two reference care units 
for the treatment of leprosy in the city of Recife, nor-
theastern Brazil, in 2003. Patients were diagnosed and 
treated in accordance with the Brazilian Ministry of 
Health guidelines.
This investigation was designed as a retrospective case-
control study with 310 patients. A total of 155 patients 
undergoing leprosy retreatment after considered cured 
were included in the case group. The same number 
of patients who received specifi c treatment during 
the same period (with a margin of ± two years) in the 
same care units and who were considered cured and 
INTRODUCTION
* Ministério da Saúde. Fundação Nacional de Saúde. Centro Nacional de Epidemiologia. Sistema Nacional de Agravos de Notifi cação/Banco 
de Dados. Brasília. 2002.
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had not undergone leprosy retreatment were included 
in the control group. Controls were matched to cases 
on the basis of year of leprosy diagnosis and care unit 
attended to minimize or eliminate the confounding 
effect of these two factors. Patients who were retreated 
after treatment abandonment and those retreated due 
to incorrect allocation of the therapeutic regimen were 
excluded from the study. The decision to provide re-
treatment was made by experienced leprosy clinicians 
working under routine conditions, after careful clinical 
and slit-skin smear examinations and, in few cases, 
skin biopsies.
Data were obtained from a secondary database and 
validated with the medical records from the reference 
units. The following risk factors potentially associated 
with retreatment were studied: therapeutic regimen; 
classifi cation (based on clinical criteria and slit-skin 
smear examination); initial and fi nal bacterial index; 
presence of reactions after treatment; type of reaction; 
therapeutic regimen for the reaction; and reports of 
household contacts with leprosy.
The sample size was estimated based on the desired 
values for the probabilities of type I (α) and type II 
(β) error, respectively, 0.05 and 0.20, and assuming a 
frequency of exposure (post-treatment reaction) of 50% 
and an odds ratio (OR) of 2.0 (based on a pilot study 
as no previously published reports were found in the 
literature). Based on these parameters, the sample size 
estimated was 148 individuals for each group.
The associations between the dependent variable and 
each of the independent variables were investigated 
using calculations of matched OR, 95% confi dence 
intervals and p-values (p<0.05). Multivariate analysis 
was carried out with conditional logistic regression. 
The model was initially saturated with all variables that, 
in a preceding univariate model, had a p-value <0.10 
for its association with the outcome, and the statistical 
signifi cance of dropping each variable out was tested. 
Data analysis was conducted using Epi Info version 
6.04, SPSS-PC version 8.0, and the Stata 8 packages.
The study was approved by the Ethics Committee of the 
Universidade de Pernambuco (CISAM/UPE – Protocol 
No. 046/2002).
RESULTS
The time elapsed from the beginning of leprosy treat-
ment was similar in both groups due to the matching, 
≤ 1 year for 68.5% of the patients, > 1 and ≤ 2 years 
for 16.5% and ≥ 3 for 15.0%.
Univariate analysis showed no statistically signifi cant 
associations between retreatment and sex, age group, 
operational classifi cation and initial bacterial index. 
Reports of household contacts with leprosy and fi nal 
bacterial index were associated with retreatment. 
Patients who had reactions after treatment were about 
twice as likely to require retreatment as those who did 
not have any reactions after treatment completion. Type 
of reaction and the therapeutic regimen used for treating 
reactions were not associated with retreatment. Patients 
who received dapsone monotherapy were ten times 
more likely to undergo retreatment (Table 1).
Using a step-down procedure, the conditional multiple 
logistic regression analysis indicated that the following 
variables were independently associated with the outco-
me (retreatment): reaction after treatment, fi nal bacterial 
index, reports of household contacts and therapeutic 
regimen remained in the fi nal model (Table 2). The 
adjusted odds ratios (OR) were very similar to those 
obtained in the univariate analysis, thereby suggesting 
that confounding effects of each variable on other 
variables were small or nonexistent.
DISCUSSION
The present study indicates that the multiple factors 
for leprosy retreatment are presence of a reaction after 
treatment completion, reports of household leprosy 
contacts, dapsone monotherapy and a fi nal bacterial 
index ≥ 1.
A broad approach was taken to identify risk factors for 
retreatment among patients with history of previous 
leprosy treatment. This approach differs from that of 
most previous studies that focused either on relapse or 
leprosy reactions. This knowledge may contribute to 
the development of potential preventive measures for 
avoiding unnecessary retreatment. In addition to further 
studies, this knowledge may help achieving reduced 
retreatment rates and benefi t patients at an individual 
level, and contributes towards better organizing health 
care provision.
These patients were presumably relapsed patients fol-
lowing the criteria proposed by the Brazilian Ministry 
of Health. Nonetheless, there may have been a propor-
tion of false positives, i.e., patients with immunological 
reactions who were diagnosed as relapse cases. Fur-
thermore, even if immunological reactions are ruled 
out, active disease may have been due to bacterial 
persistence or to reinfection caused by the irreversible 
immunological defi ciency specifi c to Mycobacterium 
leprae.
Relapse among paucibacillary patients nearly always 
requires differential diagnosis with delayed reversal 
reaction1,7,11 and there is no gold standard for compari-
son, since M. leprae cannot be isolated in these cases.8 
Among multibacillary patients, reversal reactions are 
also frequently misdiagnosed as relapses but diagnostic 
confi rmation is possible by means of slit-skin smear 
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attend health units, and greater frequency of attendance 
may increase the likelihood that a subject will receive 
retreatment.
Patients who had reactions after treatment were about 
twice as likely to require retreatment as those who did 
not have any reactions after treatment completion. Brito 
et al2 (2005) described the case series of the 155 patients 
who were being retreated for relapse. These authors 
examination, bacillus detection, histology, and inocula-
tion in mouse footpads. These resources, however, may 
not be available under routine conditions.
Although the diagnosis of adverse immunological 
reactions was made by experienced leprosy clinicians, 
misdiagnosis may nevertheless have occurred. In addi-
tion, patients treated for leprosy with new skin lesions 
(including immunological reactions) are more likely to 
Table 1. Univariate analysis of risk factors associated with leprosy retreatment. Recife, northeastern Brazil, 2003. N=310
Risk factor category
Retreatment
Yes No Matched OR 95% CI p-value
Age 0.0537
<14 years 23 28 1
14–60 years 121 104 1.47 0.79;2.75
>60 years 13 24 0.64 0.27;1.51
Sex 0.4610
Male 74 80 1
Female 81 75 1.2 0.73;1.94
Operational classifi cation 0.7220
Paucibacillary 79 76 1
Multibacillary 72 79 0.91 0.57;1.46
Initial bacterial index 0.0985
0.0 84 95 1
0.1 to 3.0 15 21 0.71 0.34;1.49
>3 20 11 2.07 0.94;4.52
Therapy regimen 0.0009
Multidrug therapy 124 139 1
Monotherapy 23 15 10 1.28;78.11 
Reaction after treatment 0.0157
No 52 22 1
Yes 101 132 2.3 1.18;4.83
Type of reaction 0.2749
No reaction 80 91 1
Type 1 16 16 1.37 0.71;2.66
Type 2 32 23 2.82 1.06;7.47
Type 1 and 2 15 06 0.78 0.33;1.81
Unknown 10 18 1.01 0.41;2.49
Management of reaction 0.5303
Corticoid + thalidomide 17 18 1
Corticoid 48 38 1.40 0.64;3.09
Thalidomide 07 06 1.26 0.34;4.62
Final bacterial index 0.0241
Negative 26 37 1
<1 06 06 1.33 0.35;4.97
>1 14 03 6.43 1.67;24.74
Not performed
Reports of household contact with leprosy 0.0130
No 78 104 1
Yes 40 28 2.2 1.17;4.03
* Numbers vary because of missing information for certain variables. 
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showed that 65% were classifi ed as multibacillary and 
the most common manifestations were macular erup-
tion and infi ltration. It was highly remarkable that the 
most common lesions in multibacillary patients with 
relapse were nodules and papules. According to Gebre 
et al5 (2000), the diagnosis of relapse in leprosy cases 
are somewhat diffi cult to establish, thus paucibacillary 
patients should use corticosteroids for a six-month pe-
riod while multibacillary patients should use them for 
a one-year period, with or without specifi c therapeutic 
treatment, in an attempt to protect patients against 
neural damage. If lesions recede, it may be assumed 
that a reaction has occurred. If lesions remain, relapse 
needs to be further investigated.
Leprosy patients reporting household contacts were 
twice as likely to require retreatment. No investigation 
regarding whether or not households contacts had active 
disease was undertaken. Nevertheless, it is reasonable to 
assume that this fi nding indicates the possibility of rein-
fection given the irreversible immunological defi ciency 
specifi c to M. leprae as suggested by Reddy & Cherian8 
(1991) and Gallo & Oliveira3 (1997). No studies were 
found in the literature addressing the importance of con-
tacts with regard to retreated patients. More complex 
studies using a cohort design may contribute towards 
elucidating these issues.
The study fi nding that patients who received dapsone 
monotherapy were ten times more likely to require 
retreatment support the fact that monotherapy regimens 
have limited effectiveness, as well-documented in the 
literature.
A slit-skin smear examination at the end of treatment 
was carried out only on 26.6% of the patients studied 
(92/310), and patients with a fi nal bacterial index ≥ 1 
were six times more likely to require retreatment. These 
results, however, should be interpreted with caution 
due to the small number of patients studied. Sampling 
variability and selection bias cannot be excluded as 
alternative explanations. These results could also be 
due to misclassifi cation, depending on the extent to 
which adverse immunological reactions may have 
been misdiagnosed as relapses. In studying relapse 
among multibacillary patients, Girdhar et al6 (2000) 
suggested there was an increase in the bacterial index 
before the onset of lesions. Jamet & Baohong7 (1995) 
recommended that patients with initial bacterial index 
≥ 4 and fi nal bacterial index ≥ 3 should be monitored 
and that examinations should be carried out in higher-
quality reference laboratories.
These findings cause some concern regarding the 
follow-up procedures needed for these patients. The 
Brazilian Ministry of Health assumes that cure is 
achieved based on the number of doses and regularity 
of treatment only. The study results indicate that efforts 
should be made to improve the quality of laboratory 
tests and to make them available at the primary care 
level. Further investigations using a cohort design and 
larger sample size are needed to evaluate the associa-
tion between the bacterial index, especially at the end 
of treatment, and retreatment.
The statistically signifi cant association between post-
treatment reactions and retreatment found in the present 
study are consistent with two hypotheses that should 
be further investigated. First, the presence of reaction 
after treatment completion increases the risk of relapse. 
Second, patients are being retreated not because they 
have relapses but because of reactions misdiagnosed 
in the clinical evaluation.
The present study on leprosy retreatment has raised 
questions that require additional approaches from 
a public health and clinical perspective. How many 
patients have adverse immunological reactions? How 
many are cases of bacterial persistence? Is the fi nal 
bacterial index no longer needed at the end of treatment 
of multibacillary patients? How many patients are rein-
fected through household contacts? Further studies are 
needed to address these questions, particularly by using 
a cohort design and incorporating molecular biology 
techniques. Also, special monitoring procedures must 
be implemented after ascertaining cure of patients who 
are more likely to require retreatment.
In conclusion, the study fi ndings reinforce that the use 
of dapsone monotherapy should be discontinued and 
there is need for special monitoring of specifi c groups 
of leprosy patients, i.e., those who have household 
contacts with leprosy, those showing reactions after the 
completion of treatment and those with a fi nal bacterial 
index ≥ 1, through periodical clinical and laboratory 
evaluations.
Table 2. Logistic regression model of risk factors associated 
with leprosy retreatment. Recife, northeastern Brazil, 2003.
Variable 
Matched 
adjusted OR
95% CI 
Reaction after treatment
No 1.0 –
Yes 2.42 1.08;5.38 
Final bacterial index
Negative 1.0 –
<1 1.3 0.355;4.979
>1 4.9 1.19;20.51
Reports of household contacts
No 1.0 –
Yes 2.17 0.23;0.93 
Drug regimen
Multidrug therapy 1.0 –
Monotherapy 10.0 1.43;94.6
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